Bristol-Backed Program May Spur Immunotherapy Use In Community Setting
This article was originally published in The Pink Sheet Daily
Executive Summary
With Yervoy/Opdivo melanoma combo and Keytruda lung cancer approvals right around the corner, a new educational program from the Association of Community Cancer Centers aims to encourage immunotherapy adoption outside of academic centers.